{"id":"NCT01583374","sponsor":"Amgen","briefTitle":"Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis","officialTitle":"A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF APREMILAST (CC-10004) IN THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-05-02","primaryCompletion":"2014-02-24","completion":"2018-10-25","firstPosted":"2012-04-24","resultsPosted":"2015-03-17","lastUpdate":"2020-05-12"},"enrollment":490,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Ankylosing Spondyloarthritis"],"interventions":[{"type":"DRUG","name":"Apremilast tablet 20 mg","otherNames":["Otezla; CC-10004"]},{"type":"DRUG","name":"Apremilast tablet 30 mg BID","otherNames":["Otezla; CC-10004"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Apremilast 20 mg","type":"EXPERIMENTAL"},{"label":"Apremilast 30 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Apremilast is a new, orally available, small molecule drug that specifically inhibits phosphodiesterase 4 (PDE4), an enzyme that modulates inflammatory cytokines. This clinical study tests whether apremilast can improve the signs and symptoms of ankylosing spondylitis.","primaryOutcome":{"measure":"Percentage of Participants Who Achieved an Assessment of SpondyloArthritis International Society 20 (ASAS 20) Response at Week 16","timeFrame":"Baseline and Week 16","effectByArm":[{"arm":"Placebo","deltaMin":36.6,"sd":null},{"arm":"Apremilast 20 mg","deltaMin":35,"sd":null},{"arm":"Apremilast 30 mg","deltaMin":32.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.4383"},{"comp":"OG000 vs OG001","p":"0.7427"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":null},"locations":{"siteCount":103,"countries":["United States","Australia","Austria","Bulgaria","Canada","Czechia","Estonia","France","Germany","Hungary","Netherlands","Poland","Romania","Russia","Slovakia","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["30018799","31077258","33589554"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":164},"commonTop":["Diarrhoea","Nasopharyngitis","Upper respiratory tract infection","Nausea","Headache"]}}